These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 31863928

  • 1. Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw.
    Li J, Wang W.
    J Stomatol Oral Maxillofac Surg; 2020 Jun; 121(3):264-267. PubMed ID: 31863928
    [Abstract] [Full Text] [Related]

  • 2. Pentoxifylline - a review of its use in osteoradionecrosis.
    Lyons AJ, Brennan PA.
    Br J Oral Maxillofac Surg; 2017 Apr; 55(3):230-234. PubMed ID: 28034471
    [Abstract] [Full Text] [Related]

  • 3. Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw.
    Heifetz-Li JJ, Abdelsamie S, Campbell CB, Roth S, Fielding AF, Mulligan JP.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Nov; 128(5):491-497.e2. PubMed ID: 31488389
    [Abstract] [Full Text] [Related]

  • 4. Is the use of Pentoxifylline and Tocopherol effective in the treatment of Osteoradionecrosis of the jaws or for the treatment of medicationosteonecrosis of the jaw? An overview.
    de Morais RPL, de Aguiar AWPB, da Hora Sales PH, Carvalho AAT, Vescovi P, Meleti M, Leão JC.
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(5S1):101959. PubMed ID: 38964469
    [Abstract] [Full Text] [Related]

  • 5. Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: A systematic literature review.
    Cavalcante RC, Tomasetti G.
    J Craniomaxillofac Surg; 2020 Nov; 48(11):1080-1086. PubMed ID: 32998853
    [Abstract] [Full Text] [Related]

  • 6. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Gross C, Weber M, Creutzburg K, Möbius P, Preidl R, Amann K, Wehrhan F.
    J Transl Med; 2017 Jun 06; 15(1):128. PubMed ID: 28587628
    [Abstract] [Full Text] [Related]

  • 7. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Wehrhan F, Gross C, Creutzburg K, Amann K, Ries J, Kesting M, Geppert CI, Weber M.
    J Transl Med; 2019 Mar 04; 17(1):69. PubMed ID: 30832685
    [Abstract] [Full Text] [Related]

  • 8. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Akashi M, Wanifuchi S, Iwata E, Takeda D, Kusumoto J, Furudoi S, Komori T.
    Oral Maxillofac Surg; 2018 Mar 04; 22(1):59-63. PubMed ID: 29224060
    [Abstract] [Full Text] [Related]

  • 9. Preventive Effect of Phosphodiesterase Inhibitor Pentoxifylline Against Medication-Related Osteonecrosis of the Jaw: An Animal Study.
    Yalcin-Ulker GM, Cumbul A, Duygu-Capar G, Uslu Ü, Sencift K.
    J Oral Maxillofac Surg; 2017 Nov 04; 75(11):2354-2368. PubMed ID: 28529150
    [Abstract] [Full Text] [Related]

  • 10. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
    Ngoc Thuy Tran V, Chaisuparat R.
    J Oral Pathol Med; 2021 Aug 04; 50(7):731-740. PubMed ID: 34038006
    [Abstract] [Full Text] [Related]

  • 11. Comparative clinical study of phosphorous necrosis and medical-related osteonecrosis of the jaws.
    Xie R, Wang W, Bian L, Qian Y, Li J, Zhang H.
    Clin Oral Investig; 2024 Feb 13; 28(2):147. PubMed ID: 38351377
    [Abstract] [Full Text] [Related]

  • 12. Effects of pentoxifylline and tocopherol on a rat-irradiated jaw model using micro-CT cortical bone analysis.
    Nguyen TTH, Eo MY, Seo MH, Myoung H, Kim SM, Lee JH.
    Eur Arch Otorhinolaryngol; 2019 Dec 13; 276(12):3443-3452. PubMed ID: 31414224
    [Abstract] [Full Text] [Related]

  • 13. Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences.
    Grisar K, Schol M, Schoenaers J, Dormaar T, Coropciuc R, Vander Poorten V, Politis C.
    Int J Oral Maxillofac Surg; 2016 Dec 13; 45(12):1592-1599. PubMed ID: 27427547
    [Abstract] [Full Text] [Related]

  • 14. Effect of pentoxifylline and α-tocopherol on medication-related osteonecrosis of the jaw in rats: Before and after dental extraction.
    Delfrate G, Mroczek T, Mecca LEA, Andreis JD, Fernandes D, Lipinski LC, Claudino M, Franco GCN.
    Arch Oral Biol; 2022 May 13; 137():105397. PubMed ID: 35286947
    [Abstract] [Full Text] [Related]

  • 15. Assessment of jaw osteonecrosis diagnostic criteria in cancer patients with a history of radiation therapy and exposure to bone-modifying agents.
    Zadik Y, Ganor Y, Rimon O, Bersudski E, Meirovitz A.
    Radiother Oncol; 2021 Mar 13; 156():275-280. PubMed ID: 33373641
    [Abstract] [Full Text] [Related]

  • 16. Cilostazol and Tocopherol in the Management of Medication-Related Osteonecrosis of the Jaw: New Insights From a Case Report.
    de Carvalho E F, Bertotti M, Migliorati CA, Rocha AC.
    J Oral Maxillofac Surg; 2021 Dec 13; 79(12):2499-2506. PubMed ID: 34339622
    [Abstract] [Full Text] [Related]

  • 17. Impaired Callus Formation in Pathological Mandibular Fractures in Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis.
    Van Camp N, Verhelst PJ, Nicot R, Ferri J, Politis C.
    J Oral Maxillofac Surg; 2021 Sep 13; 79(9):1892-1901. PubMed ID: 34097863
    [Abstract] [Full Text] [Related]

  • 18. CBCT imaging and histopathological characteristics of osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Ogura I, Minami Y, Ono J, Kanri Y, Okada Y, Igarashi K, Haga-Tsujimura M, Nakahara K, Kobayashi E.
    Imaging Sci Dent; 2021 Mar 13; 51(1):73-80. PubMed ID: 33828964
    [Abstract] [Full Text] [Related]

  • 19. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Minami Y, Ogura I.
    J Med Imaging Radiat Oncol; 2021 Apr 13; 65(2):160-165. PubMed ID: 33180378
    [Abstract] [Full Text] [Related]

  • 20. Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan.
    Shibahara T.
    Jpn Dent Sci Rev; 2019 Nov 13; 55(1):71-75. PubMed ID: 30949254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.